ResearcherUniversity of RochesterActive in the last 2 years
Scott A. Gerber
Matched on ORCID iD 0000-0002-5620-9693; OpenAlex author ID A5059824265. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 6)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 12
2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers
Papers 8
- Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1016/j.ijrobp.2025.06.3853↗
- Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis. Last author DOI 10.1080/2162402x.2026.2682058↗
- Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. Last author DOI 10.1136/jitc-2024-010820↗
- Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer. Last author DOI 10.1016/j.omtn.2024.102350↗
- CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models. Last author DOI 10.1136/jitc-2023-006842↗
- Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy. Last author DOI 10.1158/1078-0432.ccr-21-2495↗
- Increased myocellular lipid and IGFBP-3 expression in a pre-clinical model of pancreatic cancer-related skeletal muscle wasting. Co-author DOI 10.1002/jcsm.12699↗
- H-scan, Shear Wave and Bioluminescent Assessment of the Progression of Pancreatic Cancer Metastases in the Liver. Co-author DOI 10.1016/j.ultrasmedbio.2020.08.006↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- David C. Linehan · 7 shared papers, 2021–2026 · strength 1.24
- Paper Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Ade… DOI 10.1016/j.ijrobp.2025.06.3853↗
- Paper Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis. DOI 10.1080/2162402x.2026.2682058↗
- Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
- Angela L. Hughson · 5 shared papers, 2023–2026 · strength 0.98
- Paper Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Ade… DOI 10.1016/j.ijrobp.2025.06.3853↗
- Paper Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis. DOI 10.1080/2162402x.2026.2682058↗
- Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
- Haoming Qiu · 4 shared papers, 2022–2026 · strength 0.76
- Paper Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Ade… DOI 10.1016/j.ijrobp.2025.06.3853↗
- Paper Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis. DOI 10.1080/2162402x.2026.2682058↗
- Paper Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer. DOI 10.1016/j.omtn.2024.102350↗
- Tara G Vrooman · 4 shared papers, 2023–2026 · strength 0.73
- Paper Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis. DOI 10.1080/2162402x.2026.2682058↗
- Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
- Paper CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2023-006842↗
- Jian Ye · 4 shared papers, 2022–2026 · strength 0.73
- Paper Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Ade… DOI 10.1016/j.ijrobp.2025.06.3853↗
- Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
- Paper CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2023-006842↗
- Bradley N. Mills · 4 shared papers, 2022–2026 · strength 0.72
- Paper Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Ade… DOI 10.1016/j.ijrobp.2025.06.3853↗
- Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
- Paper Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer. DOI 10.1016/j.omtn.2024.102350↗
- Joseph D. Murphy · 4 shared papers, 2021–2026 · strength 0.65
- Paper Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Ade… DOI 10.1016/j.ijrobp.2025.06.3853↗
- Paper Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer. DOI 10.1016/j.omtn.2024.102350↗
- Paper Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy. DOI 10.1158/1078-0432.ccr-21-2495↗
- Laura Maria Calvi · 3 shared papers, 2024–2026 · strength 0.57
- Paper Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis. DOI 10.1080/2162402x.2026.2682058↗
- Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
- Paper Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer. DOI 10.1016/j.omtn.2024.102350↗
- Marvin M. Doyley · 1 shared paper, 2020 · strength 0.13
- Jihye Baek · 1 shared paper, 2020 · strength 0.13
- Alan W. Katz · 1 shared paper, 2022 · strength 0.13
- Calvin Lloyd Cole · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.